EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis






Journal of Biological Chemistry 260(24): 12895-8

The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis

The amino acid sequence of human tissue amyloid P component (AP) extracted by a modified method from the spleen of a patient with primary idiopathic amyloidosis was determined. AP is a glycoprotein composed of a pair of noncovalently bound pentameric discs with a subunit size of 23-25 kDa. Each subunit consists of 204 residues, a single disulfide bridge linking Cys 36 to Cys 95, and a carbohydrate moiety attached to Asn 32. The precursor of AP is the serum amyloid protein (SAP). The primary structure of AP presented here differs from the amino acid sequence of SAP previously reported, but is identical to the amino acid sequence of mature SAP deduced from the nucleotide sequence of complementary DNA clones. It shares 52% homology with the amended sequence of human C-reactive protein, an acute phase protein, and 68% homology with the Syrian hamster "female protein", another acute phase protein whose response is modulated by sex steroids. AP/SAP, C-reactive protein, and female protein belong to a family of plasma proteins called pentraxins and their considerable sequence homology is probably the result of gene duplication. Neither the physiological function of AP nor its possible pathological role in amyloidosis are yet known.


Accession: 006740926

PMID: 4055725



Related references

Breathnach, S.M.; Melrose, S.M.; Bhogal, B.; de Beer, F.C.; Black, M.M.; Pepys, M.B., 1983: Ultrastructural localization of amyloid P component in primary localized cutaneous amyloidosis. Clinical and Experimental Dermatology 8(4): 355-362

Facon, T.; Maulin, L.; Hachulla, E.; Deveaux, M.; Bietry, O.; Vanhille, P.; Hatron, P.Y.; Wechsler, B.; Godeau, P.; Bauters, F.; Marchandise, X., 1993: Assessment of primary amyloidosis with serum amyloid P component scintigraphy From diagnosis to prognosis. Blood 82(10 SUPPL 1): 563A

Maulin, L.; Hachulla, E.; Facon, T.; Deveaux, M.; Blétry, O.; Vanhille, P.; Wechsler, B.; Godeau, P.; Levesque, H.; Marchandise, W., 1993: Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis. Purified human SAP labeled with iodine-123(123I-SAP) was given intravenously to 24 patients with biopsy-proved systemic primary amyloidis. Spleen and liver distribution of amyloidis is mostly revealed by 123I-SAP scintigraphy and the importance of...

Gray S.C.; Mantzouranis E.C.; Cohen A.S.; Skinner M., 1991: Quantification of amyloid p component in multiple tissues of patients with primary and familial amyloidosis. Natvig, J B , Et Al (Ed ) Amyloid And Amyloidosis, 1990; Vith International Symposium on Amyloidosis, Oslo, Norway, August 5-8, 1990 Xxviii+937p Kluwer Academic Publishers: Dordrecht, Netherlands; Norwell, Massachusetts, Usa Illus Maps 260-263

Anderson, J.K.; Mole, J.E., 1982: Large scale isolation and partial primary structure of human plasma amyloid P-component. Annals of the New York Academy of Sciences 389: 216-234

Hachulla, E.; Maulin, L.; Deveaux, M.; Facon, T.; Blétry, O.; Vanhille, P.; Wechsler, B.; Godeau, P.; Levesque, H.; Hatron, P.Y.; Huglo, D.; Devulder, B.; Marchandise, X., 1996: Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis. The purpose of this study was to assess the value of the serum amyloid P (SAP) component scintigraphy in patients with primary amyloidosis (AL). Pure human SAP labeled with iodine-123 (123I-SAP) was given intravenously to 24 patients with biopsy-p...

Hachulla, E.; Maulin, L.; Deveaux, M.; Facon, T.; Bletry, O.; Vanhille, P.; Wechsler, B.; Godeau, P.; Levesque, H.; Hatron, P.Y.; Huglo, D.; Devulder, B.; Marchandise, X., 1996: Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: From diagnosis to prognosis. OBJECTIVE: The purpose of this study was to assess the value of the serum amyloid P (SAP) component scintigraphy in patients with primary amyloidosis (AL). MATERIAL AND METHODS: Pure human SAP labeled with iodine-123 (123I-SAP) was given intraveno...

Gray S.C.; Mantzouranis E.; Cohen A.S.; Skinner M., 1990: Amyloid p component in heart liver and spleen tissues of patients with primary and familial types of amyloidosis. Arthritis & Rheumatism 33(9 SUPPL): S90

Fujimoto, N.; Yajima, M.; Ohnishi, Y.; Tajima, S.; Ishibashi, A.; Hata, Y.; Enomoto, U.; Konohana, I.; Wachi, H.; Seyama, Y., 2002: Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis. Primary localized cutaneous nodular amyloidosis is a rare form of cutaneous amyloidosis. Amyloid fibrils in primary localized cutaneous nodular amyloidosis have been reported to be originated from immunoglobulin light chains. Immunohistochemical s...

Fujimoto, N.; Yajima, M.; Ohnishi, Y.; Tajima, S.; Ishibashi, A.; Hata, Y.; Enomoto, U.; Konohana, I.; Wachi, H.; Seyama, Y., 2002: Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis. Primary localized cutaneous nodular amyloidosis is a rare form of cutaneous amyloidosis. Amyloid fibrils in primary localized cutaneous nodular amyloidosis have been reported to be originated from immunoglobulin light chains. Immunohistochemical s...